Pharma’s Pervasive Influence Corrupts Medicine both sides of Atlantic Tue, 4 Oct 2005 The focus of criticism in medicine has shifted from cost and barriers to access to treatments to an examination of the safety and benefit of current treatments. The pharmaceutical industry’s corrupting influence on physicians, academic researchers, the…
July 16, 2002 Genetic Testing Raises Tough Ethical Questions FYI An Op Ed article in The New York Times, by Susan Love, MD, sheds light on the faulty assumptions that led to the discovery that hormone replacement therapy did not deliver on its promises. “There is a tendency, driven by…
Dubious Drug Therapy – Keith Koeller / Bread and Shelter, Yes. Psychiatrists, No – Sally Satel Wed, 30 Mar 2005 Two OpEd columns deserve special attention because they provide insight and evidence of the harm done by current psychiatric / psychological practices. Sally Satel, MD is a psychiatrist and resident…
Instead of a War against Drugs, Children Riddled with Psych Drugs Tue, 14 Jan 2003 In his 1994 book, The War on Children, psychiatrist, Dr. Peter Breggin exposed the practice of prescribing psychiatric drugs as a method for controlling children’s behavior. Dr. Breggin was reviled by the psychiatric establishment, even…
"The drugs most commonly used to soothe agitation and aggression in people with Alzheimer’s disease are no more effective than placebos for most patients, and put them at risk of serious side effects, including confusion, sleepiness and Parkinson’s disease-like symptoms, researchers are reporting
today."
Two actions by the FDA last week demonstrate where the agency’s priority lies—and that priority is NOT to protect public safety, NOT to protect children’s safety. FDA’s priority—as demonstrated by its actions—is approval of new drugs or approval for expanded even dubious uses of patented drugs.
“a study published yesterday overturns conventional wisdom about antipsychotic drugs, which cost the United States $10 billion a year.”
No legitimate physician would use the physician’s professional license to help repressive government regimes intimidate dissidents.
Industry’s blockbuster sellers–the atypical antipsychotics performed WORSE than their cheaper, non-patented precursors.
"Even though clinical research is a noble and worthy activity, it’s very easy to lose your moral compass if your primary goal is the dollar amount of grant funding that you generate."
Steven Potkin, who, LAT reports, is a brother-in-law of Jane Pauley who wrapped up her career as TV news anchor to become a paid drug pusher.
8, 362 consumers of Lilly’s top-selling drug that produces diabetes–among other life-threatening effects–can expect between $5,000 to "well over $100,000 a person" depending upon the harm suffered.
